DMRA
Damora Therapeutics, Inc.
20.20$
-2.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +61.3% | +203.1% | -28.8% | -40.1% | -47.8% | -55.2% | +1,420.7% | |
| – | +60.4% | +201.9% | -35.0% | -42.0% | -42.5% | -54.2% | +1,446.5% | |
| – | -63.6% | +1,348.4% | -61.8% | -47.6% | -34.5% | -34.0% | +1,717.5% | |
| – | -63.6% | +1,348.4% | -38.8% | -39.9% | -45.0% | -57.2% | +1,717.5% | |
| – | +4,058.5% | -94.6% | +3.2% | -39.5% | +24.6% | -48.7% | +2.0% | |
| – | +83.1% | -25.0% | -18.3% | +129.1% | -48.4% | -54.9% | +657.1% | |
| – | +78.4% | -29.8% | -18.4% | +144.4% | -47.5% | -79.5% | +1,576.4% | |
| – | – | +329.9% | +6.7% | +19.3% | -61.6% | -93.4% | +25.0% | |
| – | +135.4% | -14.4% | -46.3% | +118.8% | -49.2% | -77.8% | +17.8% | |
| – | +58.1% | +241.4% | -29.2% | -47.3% | -47.6% | -55.2% | +1,561.1% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | -0.7% | +0.0% | +0.6% | +4.6% | +8.9% | +17.8% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.